WADA 2027 Prohibited List: what it says about peptides
Thymalfasin (thymosin alpha-1): where it is approved and why
RFK Jr.’s peptide policy explained: HHS lets pharmacies compound BPC-157 and 5 more (Oct 2026)
Retatrutide Phase 3 (TRIUMPH): results so far, including knee osteoarthritis
FDA Warning Letters to Peptide Sellers (2024–2026)
FDA Peptide Advisory Committee Vote (July 2026)